Literature DB >> 8388906

Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection.

P A Offit1, E J Hoffenberg, N Santos, V Gouvea.   

Abstract

The humoral and cellular immune response after symptomatic, primary rotavirus infection was examined in 8 children < 2 years old. Rotavirus-specific IgA, rotavirus-specific helper T (Th) cells, and neutralizing antibody responses were evaluated at the time of illness, 2-8 weeks later, and 3-5 months later. In addition, rotavirus strains associated with infection were tested by polymerase chain reaction analysis using oligonucleotide primers specific for genes 4 (P type) and 9 (G type). The absence of rotavirus-specific IgA or rotavirus-specific helper T cell activity at the time of illness was consistent with a primary infection in 7 of 8 children. Two children were infected with serotype 1 (P type 1, G type 1), 3 with serotype 3 (P type 1, G type 3), and 3 with serotype 4 (P type 1, G type 4) strains. Neutralizing antibodies were directed against the gene 4 (P type) protein product (vp4). Because all infecting strains were P type 1, convalescent antisera did not distinguish among different rotavirus G types. Rotavirus-specific IgA responses were detected in 6 of 8 and rotavirus-specific Th cell responses in 7 of 8 children during convalescence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388906     DOI: 10.1093/infdis/167.6.1436

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Rotavirus-specific T-cell responses in young prospectively followed-up children.

Authors:  M Mäkelä; J Marttila; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

2.  Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes.

Authors:  M Mäkelä; V Oling; J Marttila; M Waris; M Knip; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Authors:  Ulrich Desselberger; Hans-Iko Huppertz
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

4.  Design and Antigenic Epitopes Prediction of a New Trial Recombinant Multiepitopic Rotaviral Vaccine: In Silico Analyses.

Authors:  Sima Jafarpour; Hoda Ayat; Ali Mohammad Ahadi
Journal:  Viral Immunol       Date:  2015-05-12       Impact factor: 2.257

5.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

6.  Interaction of rotavirus with human myeloid dendritic cells.

Authors:  Carlos F Narváez; Juana Angel; Manuel A Franco
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.

Authors:  S Ishida; N Feng; B Tang; J M Gilbert; H B Greenberg
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 8.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

9.  Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay.

Authors:  Robin M Kaufhold; Jodie A Field; Michael J Caulfield; Su Wang; Heather Joseph; Melissa A Wooters; Tina Green; H Fred Clark; David Krah; Jeffrey G Smith
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

10.  Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection.

Authors:  K Johansen; L Granqvist; K Karlén; G Stintzing; I Uhnoo; L Svensson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.